UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials

European journal of clinical nutrition, 2014-04, Vol.68 (4), p.416-423

2014

Volltextzugriff (PDF)

Effect of canagliflozin on liver function tests in patients with type 2 diabetes

Diabetes & metabolism, 2016-02, Vol.42 (1), p.25-32

2016

Volltextzugriff (PDF)

A systematic review and meta-analysis of randomized trials of substituting soymilk for cow's milk and intermediate cardiometabolic outcomes: understanding the impact of dairy alternatives in the transition to plant-based diets on cardiometabolic health

BMC medicine, 2024-08, Vol.22 (1), p.1-16

2024

Volltextzugriff (PDF)

P290 La canagliflozine montre des améliorations durables de la glycémie sur 104 semaines par comparaison avec le glimépiride chez des patients avec un diabète de type 2 sous metformine

Diabetes & metabolism, 2014-03, Vol.40, p.A96-A96

2014

Volltextzugriff (PDF)

Persistent lipid abnormalities in statin-treated patients with diabetes mellitus in Europe and Canada: results of the Dyslipidaemia International Study

Diabetic medicine, 2011-11, Vol.28 (11), p.1343-1351

2011

Volltextzugriff (PDF)

LEADER 5: prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial

Cardiovascular diabetology, 2016-02, Vol.15 (1), p.29, Article 29

2016

Volltextzugriff (PDF)

Burnout While Working: Lessons from Pandemic and Beyond

1, 2023

Volltextzugriff (PDF)

Stimulation of Cholecystokinin-A Receptors With GI181771X does not Cause Weight Loss in Overweight or Obese Patients

Clinical pharmacology and therapeutics, 2008-02, Vol.83 (2), p.281-287

2008

Volltextzugriff (PDF)

relation of low glycaemic index fruit consumption to glycaemic control and risk factors for coronary heart disease in type 2 diabetes

Diabetologia, 2011-02, Vol.54 (2), p.271-279

2011

Volltextzugriff (PDF)

The Routledge Companion to Wellbeing at Work

1, 2017

Volltextzugriff (PDF)

Effect of adding insulin degludec to treatment in patients with type 2 diabetes inadequately controlled with metformin and liraglutide: a double-blind randomized controlled trial (BEGIN: ADD TO GLP-1 Study)

Diabetes, obesity & metabolism, 2016-07, Vol.18 (7), p.663-670

2016

Volltextzugriff (PDF)

β-cell preservation: a potential role for thiazolidinediones to improve clinical care in Type 2 diabetes

Diabetic medicine, 2005-08, Vol.22 (8), p.963-972

Leiter, L. A.

2005

Volltextzugriff (PDF)

Alirocumab efficacy and safety by body mass index: A pooled analysis from 10 Phase 3 ODYSSEY trials

Diabetes & metabolism, 2020-09, Vol.46 (4), p.280-287

2020

Volltextzugriff (PDF)

Frequency of cancer events with saxagliptin in the SAVOR-TIMI 53 trial

Diabetes, obesity & metabolism, 2016-02, Vol.18 (2), p.186-190

2016

Volltextzugriff (PDF)

Efficacy and safety of alirocumab in people with prediabetes vs those with normoglycaemia at baseline: a pooled analysis of 10 phase III ODYSSEY clinical trials

Diabetic medicine, 2018-01, Vol.35 (1), p.121-130

2018

Volltextzugriff (PDF)

Long-term maintenance of efficacy of dapagliflozin in patients with type 2 diabetes mellitus and cardiovascular disease

Diabetes, obesity & metabolism, 2016-08, Vol.18 (8), p.766-774

2016

Volltextzugriff (PDF)

Alirocumab safety in people with and without diabetes mellitus: pooled data from 14 ODYSSEY trials

Diabetic medicine, 2018-12, Vol.35 (12), p.1742-1751

2018

Volltextzugriff (PDF)

Glycaemic target attainment in people with Type 2 diabetes treated with insulin glargine/lixisenatide fixed‐ratio combination: a post hoc analysis of the LixiLan‐O and LixiLan‐L trials

Diabetic medicine, 2020-02, Vol.37 (2), p.256-266

2020

Volltextzugriff (PDF)

Gastrointestinal safety across the albiglutide development programme

Diabetes, obesity & metabolism, 2016-09, Vol.18 (9), p.930-935

2016

Volltextzugriff (PDF)

The effect of a dietary portfolio compared to a DASH-type diet on blood pressure

Nutrition, metabolism, and cardiovascular diseases, 2015-12, Vol.25 (12), p.1132-1139

2015

Volltextzugriff (PDF)

Efficacy and safety of alirocumab in insulin-treated patients with type 1 or type 2 diabetes and high cardiovascular risk: Rationale and design of the ODYSSEY DM–INSULIN trial

Diabetes & metabolism, 2017-10, Vol.43 (5), p.453-459

2017

Volltextzugriff (PDF)

Lipid-altering efficacy and safety profile of combination therapy with ezetimibe/statin vs. statin monotherapy in patients with and without diabetes: an analysis of pooled data from 27 clinical trials

Diabetes, obesity & metabolism, 2011-07, Vol.13 (7), p.615-628

2011

Volltextzugriff (PDF)

Viscosity of fiber preloads affects food intake in adolescents

Nutrition, metabolism, and cardiovascular diseases, 2009-09, Vol.19 (7), p.498-503

2009

Volltextzugriff (PDF)

Practical steps to improving the management of type 1 diabetes: recommendations from the Global Partnership for Effective Diabetes Management

International journal of clinical practice (Esher), 2010-02, Vol.64 (3), p.305-315

2010

Volltextzugriff (PDF)

1 – 25 von 1.665

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.124)
Mit Volltextzugriff
(1.398)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(641)
Life Sciences & Biomedicine
(606)
Humans
(450)
Male
(290)
Female
(275)
Biological And Medical Sciences
(194)
Middle Aged
(179)
Animals
(163)
Medical Sciences
(148)
Adult
(136)
Endocrinology & Metabolism
(135)
Diabetes
(130)
Aged
(126)
Cardiovascular System & Cardiology
(114)
Risk Factors
(113)
Cardiac & Cardiovascular Systems
(104)
Mice
(103)
Diabetes Mellitus
(95)
General & Internal Medicine
(91)
Medicine, General & Internal
(81)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Asian Theatre Journal
(96)
Insight
(50)
Diabetes
(47)
Canadian Journal Of Cardiology
(46)
Circulation
(44)
Diabetes Care
(36)
The American Journal Of Clinical Nutrition
(29)
The Journal Of Clinical Investigation
(28)
Journal Of Applied Physiology
(23)
European Heart Journal
(21)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(8)

Menü

Weitere Dienste

Einstellungen

Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials

Effect of canagliflozin on liver function tests in patients with type 2 diabetes

A systematic review and meta-analysis of randomized trials of substituting soymilk for cow's milk and intermediate cardiometabolic outcomes: understanding the impact of dairy alternatives in the transition to plant-based diets on cardiometabolic health

P290 La canagliflozine montre des améliorations durables de la glycémie sur 104 semaines par comparaison avec le glimépiride chez des patients avec un diabète de type 2 sous metformine

Persistent lipid abnormalities in statin-treated patients with diabetes mellitus in Europe and Canada: results of the Dyslipidaemia International Study

LEADER 5: prevalence and cardiometabolic impact of obesity in cardiovascular high-risk patients with type 2 diabetes mellitus: baseline global data from the LEADER trial

Burnout While Working: Lessons from Pandemic and Beyond

Stimulation of Cholecystokinin-A Receptors With GI181771X does not Cause Weight Loss in Overweight or Obese Patients

relation of low glycaemic index fruit consumption to glycaemic control and risk factors for coronary heart disease in type 2 diabetes

The Routledge Companion to Wellbeing at Work

Effect of adding insulin degludec to treatment in patients with type 2 diabetes inadequately controlled with metformin and liraglutide: a double-blind randomized controlled trial (BEGIN: ADD TO GLP-1 Study)

β-cell preservation: a potential role for thiazolidinediones to improve clinical care in Type 2 diabetes

Alirocumab efficacy and safety by body mass index: A pooled analysis from 10 Phase 3 ODYSSEY trials

Frequency of cancer events with saxagliptin in the SAVOR-TIMI 53 trial

Efficacy and safety of alirocumab in people with prediabetes vs those with normoglycaemia at baseline: a pooled analysis of 10 phase III ODYSSEY clinical trials

Long-term maintenance of efficacy of dapagliflozin in patients with type 2 diabetes mellitus and cardiovascular disease

Alirocumab safety in people with and without diabetes mellitus: pooled data from 14 ODYSSEY trials

Glycaemic target attainment in people with Type 2 diabetes treated with insulin glargine/lixisenatide fixed‐ratio combination: a post hoc analysis of the LixiLan‐O and LixiLan‐L trials

Gastrointestinal safety across the albiglutide development programme

The effect of a dietary portfolio compared to a DASH-type diet on blood pressure

Efficacy and safety of alirocumab in insulin-treated patients with type 1 or type 2 diabetes and high cardiovascular risk: Rationale and design of the ODYSSEY DM–INSULIN trial

Lipid-altering efficacy and safety profile of combination therapy with ezetimibe/statin vs. statin monotherapy in patients with and without diabetes: an analysis of pooled data from 27 clinical trials

Similar postprandial glycemic reductions with escalation of dose and administration time of American ginseng in type 2 diabetes

Viscosity of fiber preloads affects food intake in adolescents

Practical steps to improving the management of type 1 diabetes: recommendations from the Global Partnership for Effective Diabetes Management

Suchergebnisse filtern